Skip to main content

Table 6 Outcome characteristics

From: Laparoscopic and open postchemotherapy retroperitoneal lymph node dissection in patients with advanced testicular cancer – a single center analysis

Variable L-PCLND O-PCLND p Value
N = 46 N = 21
Median follow up; months (IQR) 30.1 (12.1 – 47.1) 54.5 (22.0 – 87.7) 0.033 *1
Further treatment, n (%)    
surveillance 33 (71.7) 12 (57.1) 0.020 *2
chemotherapy 3 (6.5) 6 (28.5)
thoracotomy 0 (0) 1 (4.8)
incomplete follow up 9 (19.6) 0 (0) 0.048 *2
Lost to follow up 1 (2.2) 2 (9.5) 0.229 *2
Tumor relapse, n (%) 4 (8.6) 3 (14.2) 0.415 *2
Estimated OS since PCLND in months    
Mean ± SD 83.3 ± 1.9 95.0 ± 7.4 0.447 *3
(95%CI; range) (79.6 - 87.3) (80.5 – 109.6)  
  1. Abbreviations
  2. L-PCLND – laparoscopic postchemotherapy retroperitoneal lymph node dissection; O-PCLND – open postchemotherapy retroperitoneal lymph node dissection; OS – overall survival; SD – standard deviation; n.s. - not statistically significant; *1 – Mann–Whitney U test *2 – fishers exact test; *3 – log-rank test.